Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Study Finds CB-CAPs Could Be a Biomarker for Probable Lupus

  |  Issue: January 2021  |  

Vanessa Caceres is a medical writer in Bradenton, Florida.

Study Disclosures

The study was supported by Exagen.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Ramsey-Goldman R, Alexander RV, Massarotti EM, et al. Complement activation in patients with probable systemic lupus erythematosus and ability to predict progression to American College of Rheumatology-classified systemic lupus erythematosus. Arthritis Rheumatol. 2020 Jan;72(1):78–88.
  2. Mosca M, Costenbader KH, Johnson SR, et al. Brief report: How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new classification criteria. Arthritis Rheumatol. 2019 Jan;71(1):91–98.

Related Articles

    A New Frailty Index Aids Lupus Assessment

    A recently developed frailty index may be a valuable way to quantify vulnerability in patients with systemic lupus erythe­matosus (SLE), according to a study published in Arthritis & Rheumatology.1 When evaluating SLE, physicians consider a patient’s disease activity, organ damage and health-related quality of life. The Systemic Lupus International Collaborating Clinics (SLICC)/ACR Damage Index (SDI)…